EP0873142A4 - Epreuves de selection de composes - Google Patents

Epreuves de selection de composes

Info

Publication number
EP0873142A4
EP0873142A4 EP96916950A EP96916950A EP0873142A4 EP 0873142 A4 EP0873142 A4 EP 0873142A4 EP 96916950 A EP96916950 A EP 96916950A EP 96916950 A EP96916950 A EP 96916950A EP 0873142 A4 EP0873142 A4 EP 0873142A4
Authority
EP
European Patent Office
Prior art keywords
compounds
screening assays
assays
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96916950A
Other languages
German (de)
English (en)
Other versions
EP0873142A1 (fr
Inventor
Axel Ullrich
Harald App
Klaus P Hirth
Jianming Tsai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sugen LLC
Original Assignee
Sugen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen LLC filed Critical Sugen LLC
Publication of EP0873142A1 publication Critical patent/EP0873142A1/fr
Publication of EP0873142A4 publication Critical patent/EP0873142A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP96916950A 1995-06-07 1996-06-03 Epreuves de selection de composes Withdrawn EP0873142A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48815695A 1995-06-07 1995-06-07
US488156 1995-06-07
PCT/US1996/008332 WO1996040276A1 (fr) 1995-06-07 1996-06-03 Epreuves de selection de composes

Publications (2)

Publication Number Publication Date
EP0873142A1 EP0873142A1 (fr) 1998-10-28
EP0873142A4 true EP0873142A4 (fr) 2001-08-08

Family

ID=23938536

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96916950A Withdrawn EP0873142A4 (fr) 1995-06-07 1996-06-03 Epreuves de selection de composes

Country Status (3)

Country Link
EP (1) EP0873142A4 (fr)
AU (1) AU5965896A (fr)
WO (1) WO1996040276A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
GB9619168D0 (en) * 1996-09-13 1996-10-23 Univ Cambridge Tech Assay
US5851988A (en) 1997-01-15 1998-12-22 Terrapin Technologies, Inc. Nonpeptide insulin receptor agonists
WO1999003498A1 (fr) * 1997-07-18 1999-01-28 Novo Nordisk A/S Utilisation de fvii ou fviiai pour le traitement de pathologies liees au processus de transmission des signaux intracellulaires induites par fviia
US6461610B1 (en) 1997-07-18 2002-10-08 Novo Nordisk A/S Methods for modifying cell motility using factor VIIa or inactivated factor VIIa
US6531579B1 (en) 1998-02-26 2003-03-11 Genentech, Inc. Fused polypeptides
US6022708A (en) * 1998-02-26 2000-02-08 Genentech, Inc. Fused
US6451977B1 (en) 1998-02-26 2002-09-17 Genentech, Inc. Fused polypeptides
US6780596B2 (en) * 1998-09-17 2004-08-24 Ashni Naturaceuticals, Inc. Methods for determining the activity of complex mixtures
US6355786B1 (en) 1998-10-30 2002-03-12 Vanderbilt University Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same
WO2000053801A1 (fr) 1999-03-08 2000-09-14 Merck Frosst Canada & Co. Mesure de cellules entieres pour des proteine tyrosine phosphatases
US6406869B1 (en) * 1999-10-22 2002-06-18 Pharmacopeia, Inc. Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agents
DE10323081A1 (de) * 2003-05-22 2004-12-16 Aventis Pharma Deutschland Gmbh Verwendung eines Polypeptides
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003377A1 (fr) * 1991-07-31 1993-02-18 Ziltener Hermann J Procede de detection de restes de phosphotyrosine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900529A (nl) * 1989-03-03 1990-10-01 Eurodiagnostics B V Werkwijze en kit voor het bepalen van tyrosine fosforylerende en defosforylerende activiteit.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003377A1 (fr) * 1991-07-31 1993-02-18 Ziltener Hermann J Procede de detection de restes de phosphotyrosine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9640276A1 *

Also Published As

Publication number Publication date
WO1996040276A1 (fr) 1996-12-19
EP0873142A1 (fr) 1998-10-28
AU5965896A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
IL119078A0 (en) Substituted benzylaminopiperidine compounds
AP9701021A0 (en) Novel compounds
EP0802908A4 (fr) Nouveaux composes
GB9507203D0 (en) Novel compounds
GB9509164D0 (en) Novel compounds
EP0873142A4 (fr) Epreuves de selection de composes
GB2308511B (en) Screening can
GB9503717D0 (en) Novel compounds
IL122135A0 (en) Method for screening anti-inflammatory compounds
GB9509807D0 (en) Novel compounds
GB9526355D0 (en) Novel compounds
GB9508010D0 (en) Novel compounds
GB9508327D0 (en) Novel compounds
GB9508967D0 (en) Novel compounds
GB9504400D0 (en) Novel compounds
GB9508964D0 (en) Novel compounds
GB9509165D0 (en) Novel compounds
GB9510184D0 (en) Novel compounds
GB9503648D0 (en) Novel compounds
GB9510185D0 (en) Novel compounds
GB9514875D0 (en) Novel compounds
GB9516845D0 (en) Novel compounds
GB9521148D0 (en) Novel compounds
GB9504718D0 (en) Novel compounds
GB9508955D0 (en) Novel compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI

A4 Supplementary search report drawn up and despatched

Effective date: 20010627

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE FR GB IT LI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 49/00 A, 7G 01N 31/00 B, 7G 01N 33/48 B, 7G 01N 33/53 B, 7G 01N 33/573 B, 7G 01N 33/542 B, 7G 01N 33/543 B, 7G 01N 33/551 B, 7G 01N 33/544 B, 7C 12Q 1/50 B, 7G 01N 33/50 B, 7C 12Q 1/42 B, 7C 12Q 1/48 B

17Q First examination report despatched

Effective date: 20030417

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031028